Virogin Biotech
PrivateLast Round
Series D
Sep 24, 2021
Total Funding Raised
$279M
Company Overview
Virogin Biotech is a clinical-stage immuno-oncology company developing oncolytic virotherapy and mRNA-based therapeutics to elicit an anti-tumor immune response against solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Virogin Biotech Comparables
Compare Virogin Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Binhui Biopharmaceutical Co., Ltd. | 88% | |
| ImmVira | 87% | |
| TILT Biotherapeutics | 87% | |
Virogin Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 24, 2021 | ||||
| Series C | Sep 21, 2020 | ||||
| Series B | Dec 4, 2018 |
Key People
Founding team and executive leadership
Virogin Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series C |
| 健壹资本 | Series B |
| SDIC Venture Capital | Series C |
| Panlin Capital | Series C, Series D |
| CDH Investments | Series C |
Virogin Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Virogin Biotech's valuation, stock price, and market status.